FierceBiotech  Jul 28  Comment 
UCB says that its two Phase III trials for their lupus drug epratuzumab failed. The developer said that neither of the two doses used in the identical, late-stage trials proved statistically superior to a placebo.
MedPage Today  Jul 9  Comment 
(MedPage Today) -- Less joint damage seen with certolizumab-methotrexate combo
Forbes  Jun 26  Comment 
Judd Apatow discussed his new book, Sick in the Head: Conversations About Life and Comedy ?a collection of interviews with comedians and others, some done as a teenager?and his stand-up career in a conversation last week with NPR host Ira Glass...
The Hindu Business Line  Jun 19  Comment 
Dr Reddy’s Laboratories today said it has completed the acquisition of select portfolio of established brands of Belgian firm UCB in India.“...with regard to acquisition of select portfolio...
FierceBiotech  Jun 11  Comment 
In this week's EuroBiotech Report, Biotie Therapies, Cosmo Pharmaceuticals, Targovax and Pieris Pharmaceuticals are all advancing plans to raise cash from public investors. Biotie and Pieris are following the well-trodden path to Nasdaq, although...
FierceBiotech  Jun 10  Comment 
Biotie Therapies has become the latest European biotech to ratchet up its Nasdaq IPO plans after gauging interest in the offering. But proceeds for the CNS specialist are due to stay at the same level, with the 12% rise in the overall haul coming...
The Times of India  Jun 1  Comment 
Lupin Ltd., India's second-largest drugmaker by market value, and Cipla Ltd. are among companies that bid for UCB SA's U.S. generic-drug business, people with knowledge of the matter said.
The Hindu Business Line  Apr 1  Comment 
Pharma major Dr Reddy’s Laboratories will acquire certain products of Brussels-based biopharmaceutical company UCB in India, Nepal, Sri Lanka and Maldives for ₹800 crore. The ac...
Mondo Visione  Mar 26  Comment 
A jury convicted Ebrahim Shabudin yesterday of seven felony counts of conspiracy, securities fraud and other corporate fraud offenses stemming from the failure of United Commercial Bank (UCB), announced U.S. Attorney Melinda Haag of the Northern...
The Times of India  Mar 11  Comment 
Drugmaker Dr Reddy's Laboratories Ltd (REDY.NS) is in talks to acquire the Indian operations of Belgian pharmaceutical company UCB SA (UCB.BR) for about $135 million, said a person with direct knowledge of the matter.

You may also be interested in articles related to UCB SA (UCB-BT):
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki